1- Stratton JR,
Lighty GW,
Pearlman AS,
Ritchie JL.
Detection of left ventricular thrombus by two-dimensional echocardiography: sensitivity,
specificity,
and causes of uncertainty.
Circulation.
1982;66(1):156–66.
2- Gandy SJ,
Waugh SA,
Nicholas RS,
Simpson HJ,
Milne W,
Houston JG.
Comparison of the reproducibility of quantitative cardiac left ventricular assessments in healthy volunteers using different MRI scanners: a multicenter simulation.
J Magn Reson Imaging.
2008;28(2):359–65.
3- Anderson JL,
Horne BD,
Pennell DJ.
Atrial dimensions in health and left ventricular disease using cardiovascular magnetic resonance.
J Cardiovasc Magn Reson.
2005;7(4):671–5.
4- Schultz A,
Caspar T,
Schaeffer M,
Labani A,
Jeung M-Y,
El Ghannudi S,
et al.
Late gadolinium enhancement cardiac imaging on a 3T scanner with parallel RF transmission technique: prospective comparison of 3D-PSIR and 3D-IR.
Eur Radiol.
2016;26(6):1547–55.
5- Jacquier A,
Bartoli B,
Flavian A,
Varoquaux A,
Gaubert JY,
Cohen F,
et al.
Comment j’optimise la technique d’IRM à la recherche d’un rehaussement tardif ? J Radiol.
2010 ;91(5,
Part 2):598–601.
6- Jacquier A,
Revel D,
Croisille P,
Gaubert J.,
Saeed M.
Mécanismes du rehaussement tardif myocardique et apport des produits de contraste en IRM et scanner dans le diagnostic de viabilité myocardique.
J Radiol.
2010;91(7–8):751–7.
7- Mahrholdt H,
Wagner A,
Judd RM,
Sechtem U,
Kim RJ.
Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies.
Eur Heart J.
2005;26(15):1461–74.
8- D’Ambrosio A,
Patti G,
Manzoli A,
Sinagra G,
Di Lenarda A,
Silvestri F,
et al.
The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review.
Heart.
2001;85(5):499–504.
9- Elgeti T,
Abdel-Aty H,
Wagner M,
Busjahn A,
Schulz-Menger J,
Kivelitz D,
et al.
Assessment of late gadolinium enhancement in nonischemic cardiomyopathy.
Invest Radiol.
2007;42(10):671–5.
10- Morita K,
Utsunomiya D,
Oda S,
Komi M,
Namimoto T,
Hirai T,
et al.
Comparison of 3D phase-sensitive inversion-recovery and 2D inversion-recovery MRI at 3.0 T for the assessment of late gadolinium enhancement in patients with hypertrophic cardiomyopathy.
Acad Radiol.
2013;20(6):752–7.